<?xml version="1.0" encoding="UTF-8"?>
<p id="Par260">In 1995/1996, highly active antiretroviral therapies (HAART) were introduced which combine
 <list list-type="bullet">
  <list-item>
   <p id="Par261">nucleoside reverse transcriptase inhibitors (NRTI)
    <list list-type="bullet">
     <list-item>
      <p id="Par262">specifically inhibit the viral reverse transcriptase enzyme necessary for DNA chain elongation of the virus</p>
     </list-item>
    </list>
   </p>
  </list-item>
  <list-item>
   <p id="Par263">protease inhibitors (PI)
    <list list-type="bullet">
     <list-item>
      <p id="Par264">prevent the production of active virus by interfering with the cleavage of proteins necessary for viral assembly</p>
     </list-item>
    </list>
   </p>
  </list-item>
 </list>
</p>
